Skip to Main Content

Paper Details

A serological assay to detect SARS-CoV-2 seroconversion in humans.
Nat Med
1371
2020
SARS, SARS-, SARS-CoV, SARS-CoV-2, human, humans
Author NameAffiliation
Teresa AydilloIcahn School of Medicine at Mount Sinai
Teresa AydilloGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Lisa MiorinIcahn School of Medicine at Mount Sinai
Lisa MiorinGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Erna Milunka KojicIcahn School of Medicine at Mount Sinai
Charlotte Cunningham-RundlesDivision of Clinical Immunology, Icahn School of Medicine at Mount Sinai
Charlotte Cunningham-Rundlesthe Icahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
Viviana SimonGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
  • 1 - 14

Datasets

Release 1.2